Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Jacques Besnainou
|
| gptkbp:focusesOn |
drug delivery
therapeutics |
| gptkbp:foundedYear |
2019
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Senda Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investor |
gptkb:Flagship_Pioneering
|
| gptkbp:parentCompany |
gptkb:Flagship_Pioneering
|
| gptkbp:specializesIn |
intercellular communication
platform therapeutics |
| gptkbp:technology |
gptkb:machine_learning
molecular engineering microbiome science |
| gptkbp:website |
https://sendabiosciences.com/
|
| gptkbp:bfsParent |
gptkb:Geoffrey_von_Maltzahn
|
| gptkbp:bfsLayer |
8
|